News Conference News ACC 2025 Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II L.A. McKeown March 31, 2025
News Daily News Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI Yael L. Maxwell September 08, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2022 Caitlin E. Cox July 04, 2022
News Conference News EuroPCR 2022 Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO Yael L. Maxwell May 23, 2022
News Daily News Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis Yael L. Maxwell March 09, 2022
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2021 Caitlin E. Cox May 03, 2021
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Conference News ESC 2020 Go With Aspirin Alone After TAVR When Anticoagulation Isn’t Needed: POPular TAVI Todd Neale August 30, 2020
News Daily News Should Guidelines Support TAVR for Low-Risk Patients? Two Views L.A. McKeown August 17, 2020
News Conference News EuroPCR 2020 ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead Yael L. Maxwell July 03, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Daily News Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion Yael L. Maxwell February 14, 2020
News Conference News TCT 2019 Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA Michael O'Riordan September 28, 2019
News Daily News Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data Caitlin E. Cox August 21, 2019
News Industry News Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation June 24, 2019